Remedi Maria S, Friedman Jonathan B, Nichols Colin G
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110
Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110.
J Gen Physiol. 2017 Jan;149(1):75-84. doi: 10.1085/jgp.201611653. Epub 2016 Dec 12.
Gain-of-function (GOF) mutations in the pore-forming (Kir6.2) and regulatory (SUR1) subunits of K channels have been identified as the most common cause of human neonatal diabetes mellitus. The critical effect of these mutations is confirmed in mice expressing Kir6.2-GOF mutations in pancreatic β cells. A second K channel pore-forming subunit, Kir6.1, was originally cloned from the pancreas. Although the prominence of this subunit in the vascular system is well documented, a potential role in pancreatic β cells has not been considered. Here, we show that mice expressing Kir6.1-GOF mutations (Kir6.1[G343D] or Kir6.1[G343D,Q53R]) in pancreatic β cells (under rat-insulin-promoter [Rip] control) develop glucose intolerance and diabetes caused by reduced insulin secretion. We also generated transgenic mice in which a bacterial artificial chromosome (BAC) containing Kir6.1[G343D] is incorporated such that the transgene is only expressed in tissues where Kir6.1 is normally present. Strikingly, BAC-Kir6.1[G343D] mice also show impaired glucose tolerance, as well as reduced glucose- and sulfonylurea-dependent insulin secretion. However, the response to K depolarization is intact in Kir6.1-GOF mice compared with control islets. The presence of native Kir6.1 transcripts was demonstrated in both human and wild-type mouse islets using quantitative real-time PCR. Together, these results implicate the incorporation of native Kir6.1 subunits into pancreatic K channels and a contributory role for these subunits in the control of insulin secretion.
钾通道形成孔道的亚基(Kir6.2)和调节亚基(SUR1)中的功能获得性(GOF)突变已被确定为人类新生儿糖尿病最常见的病因。这些突变的关键作用在胰腺β细胞中表达Kir6.2-GOF突变的小鼠中得到了证实。钾通道的第二个形成孔道的亚基Kir6.1最初是从胰腺中克隆出来的。尽管该亚基在血管系统中的突出作用已有充分记录,但尚未考虑其在胰腺β细胞中的潜在作用。在这里,我们表明,在胰腺β细胞中(在大鼠胰岛素启动子[Rip]控制下)表达Kir6.1-GOF突变(Kir6.1[G343D]或Kir6.1[G343D,Q53R])的小鼠会出现葡萄糖不耐受和因胰岛素分泌减少导致的糖尿病。我们还构建了转基因小鼠,其中整合了含有Kir6.1[G343D]的细菌人工染色体(BAC),使得转基因仅在Kir6.1正常存在的组织中表达。令人惊讶的是,BAC-Kir6.1[G343D]小鼠也表现出葡萄糖耐量受损,以及葡萄糖和磺脲类药物依赖性胰岛素分泌减少。然而,与对照胰岛相比,Kir6.1-GOF小鼠对钾去极化的反应是完整的。使用定量实时PCR在人类和野生型小鼠胰岛中均证实了天然Kir6.1转录本的存在。总之,这些结果表明天然Kir6.1亚基整合到胰腺钾通道中,并在胰岛素分泌的控制中发挥作用。